Cited by 43Alzheimer's disease research and treatmentsCellular transport and secretionDementia and Cognitive Impairment Research

Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer’s Disease

Open access
Alsaqati, Mouhamed, Thomas, Rhian S, Kidd, Emma J·2018·The Journals of Gerontology: Series A

Abstract

The greatest risk factor for Alzheimer's disease (AD) is advanced age, but the reason for this association remains unclear. Amyloid-β (Aβ) is produced from amyloid precursor protein (APP) primarily after APP is internalized by clathrin-mediated or clathrin-independent endocytosis. Changes in endocytosis in AD have been identified. We hypothesized that endocytic protein expression is altered during ageing, thus influencing the likelihood of developing AD by increasing Aβ production. We explored how levels of endocytic proteins, APP, its metabolites, secretase enzymes, and tau varied with age in cortical brain samples from men of three age ranges (young [20-30], middle aged [45-55], and old [70-90]) with no symptoms of dementia. Aβ40 and Aβ42 were significantly increased in old brains, while APP and secretase expression was unaffected by age. Phosphorylated GSK3β increased significantly with age, a possible precursor for neurofibrillary tangle production, although phosphorylated tau was undetectable. Significant increases in clathrin, dynamin-1, AP180, Rab-5, caveolin-2, and flotillin-2 were seen in old brains. Rab-5 also increased in middle-aged brains prior to changes in Aβ levels. This age-related increase in endocytic protein expression, not described previously, suggests an age-related upregulation of endocytosis which could predispose older individuals to develop AD by increasing APP internalization and Aβ generation.

Integrity signals

Registry

Crossref · 10.1093/gerona/glx135

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Altered expression of Rab5, clathrin, dynamin 2, and PICALM has been found in transgenic Tg2576 mice Alzheimer's disease experimental models.

    “In addition, the altered expression of Rab5, clathrin, dynamin 2, and PICALM has been found in transgenic Tg2576 mice AD experimental models [153,158].”

    From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [153]

  • Expression of endocytic proteins such as AP180, caveolin-2, clathrin, dynamin-1, flotillin-2, and Rab-5 is significantly elevated, and that change accelerates endocytosis and progresses Alzheimer's disease in aged brains.

    “The expression of endocytic proteins such as AP180, caveolin-2, clathrin, dynamin-1, flotillin-2, and Rab-5 has been found significantly elevated, and that change accelerates endocytosis and progresses AD in aged brains [153].”

    From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [153]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Alsaqati, M., Thomas, R. S., & Kidd, E. J.
Affiliations
  • Cardiff University (GB)
  • University of the West of England (GB)
Corresponding author
Kidd, Emma J
Venue
The Journals of Gerontology: Series A
Published
2017-06-26
Volume
73
Issue
3
Pages
289-298
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2711810487
Cited by
43
References
3
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 4
FWCI
1.83
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • The Journals of Gerontology Series A (publishedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Bristol Research into Alzheimer’s and Care of Elderly (BRACE)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, aging, endocytosis, amyloid-beta, amyloid precursor protein, clathrin-mediated endocytosis, GSK3β phosphorylation, tau protein, secretases, Rab5, dynamin 1, caveolin-2, flotillin-2, AP180, age-related protein expression
MeSH terms
Adult, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Clathrin, Endocytosis, Humans, Male, Membrane Proteins, Middle Aged, Risk Factors, Up-Regulation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Vesicular Transport Proteins, Monomeric Clathrin Assembly Proteins, Dynamin I, Caveolin 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review